Vanguard Personalized Indexing Management, LLC Rani Therapeutics Holdings, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$9.45 Billion
Q3 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Jul 25, 2025	SELL	$0.48 - $1.39 $2,420 - $7,009	-5,043 Reduced 24.67%	15,396 $7,000
Q1 2025 May 13, 2025	BUY	$1.25 - $1.85 $25,548 - $37,812	20,439 New	20,439 $25,000

Others Institutions Holding RANI

# of Institutions

Shares Held

6.32M

Call Options Held

29.4K

Put Options Held

Armistice Capital, LLC New York, NY

3.15M
Shares

$5.55 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

800K
Shares

$1.41 Million
0.0% of portfolio
Nan Fung Group Holdings LTD Central, K3

494K
Shares

$868,707
0.48% of portfolio
United Services Automobile Association San Antonio, TX

303K
Shares

$532,827
0.02% of portfolio
Geode Capital Management, LLC Boston, MA

191K
Shares

$335,380
0.0% of portfolio

View Full List

About Rani Therapeutics Holdings, Inc.

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $43.1M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

More about RANI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account